Cell MedX Corp. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q3 2011 to Q3 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Cell MedX Corp. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q3 2011 to Q3 2023.
- Cell MedX Corp. Net Cash Provided by (Used in) Financing Activities for the quarter ending August 31, 2023 was $0.000, a 100% decline year-over-year.
- Cell MedX Corp. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $91K, a 73.7% decline from 2022.
- Cell MedX Corp. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $346K, a 23.7% decline from 2021.
- Cell MedX Corp. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $454K, a 15.2% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)